Development and manufacturing for ophthalmic treatments

At Unither Pharmaceuticals, we leverage our industrial and regulatory expertise to serve a wide range of therapeutic areas, extending far beyond our traditional fields. Thanks to our aseptic technologies, innovation capabilities, and agile CDMO model, we support our partners in high-potential markets: wellness, food supplements, OTC, medical devices, veterinary care, etc.

Cutting-edge technologies for stand-out products

Ready-to-use solutions to expand your portfolio

Out-licensing

Our product portfolio includes turnkey formulas available for licensing, with marketing authorization or CE marking, ready for registration and commercialization. The indications covered are varied: cough and cold, fever and pain (adults and children), gastroenterology, oral health, and addiction.

Learn more

Content you might be interested in

Why trust us?

4 continents: global presence

100+ countries where our clients' products are distributed

5 billion BFS Leader

Do you have a project?

Talk to our experts

Natalia SERVOL

Ophthalmic Division Director

Ni ZENG

Head of Co-Development

Simonne FARINA

OTC Director

Other content you might be interested in

Development

Formulation and analytical development, manufacture of clinical batches, stability studies, and expertise in ophthalmic development.

Manufacturing

From technology transfer to industrial manufacturing, from small clinical batches to commercial volumes.

Regulatory Support

Comprehensive regulatory support, from pharmaceutical development to CTD/eCTD document submission.

Got questions? - Consult our FAQ

Blow-Fill-Seal can be used in several therapeutic areas:

  • Ophthalmology: eye drops for glaucoma, dry eye, infections, or post-surgery treatments.

 

  • ENT: physiological saline solutions for nasal and pediatric hygiene.

 

  • Respiratory care: nebulization solutions for asthma, COPD, or cystic fibrosis.

 

  • Injectables

BFS allows the production of sterile preservative-free single doses, thus improving safety during delivery and facilitating compliance among patients suffering from these conditions.

Yes. Certain regulatory support is always included during development and manufacturing projects. In some cases, we also offer additional regulatory services:

  • Registration strategy,
  • Full preparation of CMC modules (IMPD/IND, CTD/eCTD)
  • Variation management and inspection support.

Yes. Our regulatory teams can assist with the preparation and updating of CMC modules, including drafting dossiers, managing variations, and handling exchanges with health authorities (EMA, FDA, etc.).

We work closely with technical teams to ensure compliance with ICH and GMP requirements and have extensive experience in orphan products and projects with stringent regulatory requirements.